{"id":"W4385667677","doi":"10.1097/01.hs9.0000970376.71405.63","title":"P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Pomalidomide; Lenalidomide; Internal medicine; Tolerability; Multiple myeloma; Daratumumab; Dexamethasone; Oncology; Gastroenterology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000426081,0.0002525099,0.0002818601,0.00003118686,0.000140444,0.00002313859,0.0004194197,0.0002566297,0.00004607656],"category_scores_gemma":[0.0009591094,0.0001490583,0.0001338908,0.0004036704,0.0001627505,0.00001582305,0.0002142477,0.000270165,0.00002938209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006177396,"about_ca_system_score_gemma":0.0002443813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004822715,"about_ca_topic_score_gemma":0.0009795403,"domain_scores_codex":[0.9978865,0.0003092595,0.0005564922,0.0005146969,0.0004195702,0.0003134704],"domain_scores_gemma":[0.9983398,0.0001959281,0.0003517699,0.0009172151,0.0001157707,0.00007954082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2927387,0.01117914,0.0155999,0.0001214437,0.0005987264,0.00004499352,0.003330018,0.0009753309,0.4426603,0.00007939981,0.1455063,0.08716579],"study_design_scores_gemma":[0.4919364,0.002724742,0.01337729,0.0002990149,0.0000754597,0.000002038491,0.000935428,0.0007209449,0.4013029,0.00006757322,0.08791961,0.0006385642],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970349,0.0002493205,0.00003717099,0.0003101565,0.0004375653,0.001092148,0.0002347877,0.00003113743,0.0005728104],"genre_scores_gemma":[0.9967105,0.00006906422,0.0002650415,0.0002013417,0.0002679112,0.00007761089,0.000813229,0.0000426472,0.001552661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1991978,"threshold_uncertainty_score":0.6078421,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01946843014564231,"score_gpt":0.2564835981051531,"score_spread":0.2370151679595108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}